Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 64.71% is 69% above its 5-year average of 38.37%, near the high end of its 5-year range (-5.62%–70.53%).
2.66% above its 12-month average of 63.03%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 69.36%.
GROSS MARGIN
64.71%
GROSS MARGIN AVG TTM
63.03%
GROSS MARGIN AVG 3Y
51.22%
GROSS MARGIN AVG 5Y
38.37%
GROSS MARGIN AVG 10Y
12.08%
GROSS MARGIN AVG 15Y
28.62%
GROSS MARGIN AVG 20Y
21.41%
CURRENT VS TTM AVG
+2.66%
CURRENT VS 3Y AVG
+26.33%
CURRENT VS 5Y AVG
+68.64%
CURRENT VS 10Y AVG
+435.67%
CURRENT VS 15Y AVG
+126.06%
CURRENT VS 20Y AVG
+202.30%
SECTOR MEDIAN · HEALTHCARE
47.19%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
+37.14%
vs the sector median at left
ADMA Biologics, Inc.
Market Cap
$2.36B
Gross Margin
64.71%
TTM Avg
63.03%
3Y Avg
51.22%
5Y Avg
38.37%
Market Cap
$2.31B
Gross Margin
75.42%
TTM Avg
77.61%
3Y Avg
78.83%
5Y Avg
79.96%
Market Cap
$2.43B
Gross Margin
18.57%
TTM Avg
22.55%
3Y Avg
18.71%
5Y Avg
13.63%
Market Cap
$2.51B
Gross Margin
-61.96%
TTM Avg
-19.42%
3Y Avg
-14.39%
5Y Avg
23.74%
Market Cap
$2.17B
Gross Margin
100.00%
TTM Avg
-1064.88%
3Y Avg
-1783.56%
5Y Avg
-1442.31%
Market Cap
$2.13B
Gross Margin
32.36%
TTM Avg
32.47%
3Y Avg
32.14%
5Y Avg
31.56%
Market Cap
$2.07B
Gross Margin
97.82%
TTM Avg
97.53%
3Y Avg
97.80%
5Y Avg
96.20%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ADMA Biologics, Inc. (ADMA) | $2.36B | 64.71% | 63.03% | 51.22% | 38.37% |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.31B | 75.42% | 77.61% | 78.83% | 79.96% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | 18.57% | 22.55% | 18.71% | 13.63% |
| Disc Medicine, Inc. (IRON)vs › | $2.43B | 0.00% | 0.00% | 0.00% | 0.00% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | -61.96% | -19.42% | -14.39% | 23.74% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.17B | 100.00% | -1064.88% | -1783.56% | -1442.31% |
| Addus HomeCare Corporation (ADUS)vs › | $2.13B | 32.36% | 32.47% | 32.14% | 31.56% |
| Alvotech (ALVO)vs › | $2.05B | 60.45% | 60.99% | 17.21% | 44.81% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.07B | 97.82% | 97.53% | 97.80% | 96.20% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.76B | 84.05% | -197.31% | -176.53% | -71811.06% |
Gross Margin
64.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 69.36% |
| 2026-03-31 | 70.53% |
| 2025-12-31 | 63.82% |
| 2025-09-30 | 56.34% |
| 2025-06-30 | 55.11% |
| 2025-03-31 | 53.22% |
| 2024-12-31 | 53.88% |
| 2024-09-30 | 49.78% |
| 2024-06-30 | 53.60% |
| 2024-03-31 | 47.77% |
| 2023-12-31 | 42.06% |
| 2023-09-30 | 36.65% |
| 2023-06-30 | 27.76% |
| 2023-03-31 | 29.01% |
| 2022-12-31 | 28.36% |
| 2022-09-30 | 23.50% |
| 2022-06-30 | 22.92% |
| 2022-03-31 | 12.58% |
| 2021-12-31 | 13.31% |
| 2021-09-30 | 1.86% |
| 2021-06-30 | -5.62% |
| 2021-03-31 | -10.73% |
| 2020-12-31 | -36.94% |
| 2020-09-30 | -15.37% |
| 2020-06-30 | -73.30% |
| 2020-03-31 | -65.00% |
| 2019-12-31 | 2.87% |
| 2019-09-30 | -9.60% |
| 2019-06-30 | -59.90% |
| 2019-03-31 | -166.54% |
| 2018-12-31 | -174.68% |
| 2018-09-30 | -116.63% |
| 2018-06-30 | -107.14% |
| 2018-03-31 | -202.89% |
| 2017-12-31 | 0.67% |
| 2017-09-30 | -138.74% |
| 2017-06-30 | -27.49% |
| 2017-03-31 | 38.52% |
| 2016-12-31 | 39.47% |
| 2016-09-30 | 40.92% |
| 2016-06-30 | 40.83% |
| 2016-03-31 | 40.37% |
| 2015-12-31 | 40.18% |
| 2015-09-30 | 39.93% |
| 2015-06-30 | 39.97% |
| 2015-03-31 | 39.48% |
| 2014-12-31 | 35.73% |
| 2014-09-30 | 36.48% |
| 2014-06-30 | 37.29% |
| 2014-03-31 | 37.39% |
| 2013-12-31 | 33.40% |
| 2013-09-30 | 34.42% |
| 2013-06-30 | 34.65% |
| 2013-03-31 | 33.28% |
| 2012-12-31 | 27.33% |
| 2012-09-30 | 59.85% |
| 2012-06-30 | 38.34% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
